Serve the people or close the sale? Profit-driven overuse of injections and infusions in China's market-based healthcare system

International Journal of Health Planning and Management

Volumn 26, Issue 4, 2011, Pages 449-470

  Reynolds, Lucy ^a   Mckee, Martin ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

China; Health financing; Utilisation

Indexed keywords

DISEASE TREATMENT; HEALTH EXPENDITURE; HEALTH SERVICES; INCENTIVE; MARKET SYSTEM; PROFITABILITY; WELFARE REFORM;

ARTICLE; CHINA; CLINICAL PRACTICE; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HUMAN; INJECTION; INTERVIEW; INTRAVENOUS DRUG ADMINISTRATION; MALE; UTILIZATION REVIEW;

CHINA; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS; INTERVIEWS AS TOPIC; MALE; PHYSICIAN'S PRACTICE PATTERNS;

CHINA; GUIZHOU;

EID: 84855221977     PISSN: 07496753     EISSN: 10991751     Source Type: Journal    
DOI: 10.1002/hpm.1112     Document Type: Article

References (42)

1. Bao YP, Liu ZM. 2009. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 20(6): 399-405.
2. Blumenthal D, Hsiao W. 2005. Privatization and its discontents-the evolving Chinese health care system. N Engl J Med 353(11): 1165-1170.
3. Bowling A. 1997. Research Methods in Health: Investigating Health and Health Services. Open University Press: Buckingham.
4. Cao Y, Chen J, Cao JW. 2001. Injection Practices in Health Care Facilities of Shanghai, China. World Health Organization: Geneva.
5. Chen W, Cheng XZ, Li JM. 1995. The study of positive impact of positive list of drugs coverage on hospital use of drugs. Chinese Hospital Manage 15(7): 8-11.
6. Clayton S, Yang H, Guan J. 1993. Hepatitis B control in China: knowledge and practices among village doctors. Am J Public Health 83(12): 1685-1688.
7. Dong HL, Bogg L, Rehnberg C, Diwan V. 1999. Health financing policies: providers' opinions and prescribing behaviour in rural China. Int J Technol Assess Health Care 15(4): 686-698.
8. Hoyos A, Cobo U, Aristizábal B, Córdoba F, Montes de Correa C. 2008. Total suspended particulate, polychlorinated dibenzodioxin and polychlorinated dibenzofuran emissions from medical waste incinerators in Antioquia, Colombia. Chemosphere 73(1 Suppl): S137-S142.
9. Ip P-K. 2005. Developing medical ethics in China's reform era. Developing World Bioethics 5(2): 176-187.
10. Ji K, Chen J, Li M, et al. 2009. Comments on serious anaphylaxis caused by nine Chinese herbal injections used to treat common colds and upper respiratory tract infections. Regul Toxicol Pharmacol 55(2): 134-138.
11. Kleinman A. 1980. Patients and Healers in the Context of Culture: an Exploration of the Borderland between Anthropology, Medicine, and Psychiatry. University of California Press: Berkeley.
12. Lau WK, Ng MK. 1986. Illness behaviour in the Chinese patients-observations from a rural general practice. Hong Kong Practitioner 8(8): 1989-1996.
13. Li Q, Ou JM, Zeng G. 2003. A cross-sectional survey on injection safety in health facilities in Wulong county, Chongqing city. Zhonghua Liu Xing Bing Xue Za Zhi 24(3): 176-179.
14. Liang X, Bi S, Yang W, et al. 2009. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 200(1): 39-47.
15. Liu X, Li S. 1997. Drug policy in China. Transformations, current status and future prospects. Pharmacoeconomics 12(1): 1-9.
16. Liu X, Liu Y, Chen N. 2000. The Chinese experience of hospital price regulation. Health Policy Plan 15(2): 157-63.
17. Liu X, Mills A. 1999. Evaluating payment mechanisms: how can we measure unnecessary care? Health Policy Plan 14(4): 409-413.
18. Liu Y, Berman P, Yip W, et al. 2006. Health care in China: the role of non-government providers. Health Policy 77(2): 212-220.
19. Lu E. 2005. Strengthening control of antibiotics. Retrieved 12th April 2008, from
20. Lu FM, Zhuang H. 2009. Management of hepatitis B in China. Chin Med J (Engl) 122: 3-4.
21. Meng Q, Cheng G, Silver L, et al. 2005. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals. Health Policy Plan 20(3): 185-196.
22. Ministry of Health. 2005. Report on China's Healthcare System and Reform. Ministry of Health: Beijing.
23. Murakami H, Kobayashi M, Zhu X, et al. 2003. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China. Soc Sci Med 57(10): 1821-1832.
24. Oxman AD, Thomson MA, Davis DA, et al. 1995. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Cmaj 153(10): 1423-1431.
25. Reeler AV. 1990. Injections: a fatal attraction? Soc Sci Med 31(10): 1119-1125.
26. Reeler AV, Hematorn C. 1978. Injection Practices in the Third World: a Case Study of Thailand. WHO Action Programme on Essential Drugs. WHO: Geneva.
27. Reynolds L, McKee M. 2008. Possible risks of transmission of blood-borne infection via acupuncture needles in Guizhou province, southwest China. J Altern Complement Med 14: 1281-1285.
28. Reynolds L, McKee M. 2009. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy 90: 32-36.
29. Reynolds L, McKee M. 2010. Matching supply and demand for blood in Guizhou province, China: an unresolved challenge. J Public Health 32(i): 103-109.
30. Sanderson C, Bosch T, Goosen J, et al. 1987. Reviewing the process and outcome of hospital care in Europe: the tracer method. Int J Health Plann Manage 2(4): 293-299.
31. Sciortino R.1993. The myth of injections: providers and patients in rural central Java. In The Impact of Injections on Daily Medical Practice, I Wolffers, M Bloem (eds). VU University Press: Amsterdam.
32. State Council of China. 2009. Implementation plan for the recent priorities of the healthcare system reform (2009-2011).
33. Ulin PR, Robinson ET, Tolley EE, et al. 2005. Qualitative Methods in Public Health: a Field Guide for Applied Research. CA Jossey-Bass: San Francisco.
34. UNGASS. 2008. People's Republic of China Reporting period January 2006-December 2007 State Council AIDS Working Committee Office and UN Theme Group on AIDS.
35. Valavanidis A. 2008. Metal leachability, heavy metals, polycyclic aromatic hydrocarbons and polychlorinated biphenyls in fly and bottom ashes of a medical waste incineration facility. Waste Manag Res 26(3): 247-255.
36. Yan Y, Zhang G, Chen Y, et al. 2006. Study on the injection practices of health facilities in Jingzhou district, Hubei, China. Indian J Med Sci 60(10): 407-416.
37. Yan YW, Yan J, Zhang GP, et al. 2007. Prevalence of injections and knowledge of safe injections among rural residents in central China. Singapore Med J 48(8): 769-774.
38. Yang YH, Shen XZ. 2005. An overview of antibiotic resistance and usage found in past studies. Second National Workshop on Rational Use of Antibiotics in China, Beijing.
39. Yip R, UNICEF. 2003. Personal communication. Beijing.
40. Zhang X, Feng Z, Zhang L, et al. 2003. Analysis on quality of prescription of township hospitals in poor areas. J Rural Health Serv Manage 23(12): 33-35.
41. Zhen SZ, Wang F, Wang LX, et al. 1995. The benefit analysis of 'revenue control and structure adjustment' policy. China J Hospital Admin 11(9): 624-625.
42. Zheng X, Hillier S. 1995. The reforms of the Chinese health care system: county level changes: the Jiangxi Study. Soc Sci Med 41(8): 1057-1064.